InvestorsHub Logo

Dickmo

08/23/18 10:05 AM

#33851 RE: StockHighAlert- #33849

Medifirst seems to take these updates seriously. I notice a pattern of these updates and I fully support this. As an investor, this is our ability to hear about what is going on from a marketing and product basis in a simple narrative.

It is great to hear that the Time Machine Laser is receiving an enthusiastic reception in Asia. It is a huge market. Drug free pain relief can become the basis for chains of retail pain treatment clinics and new product lines for medical and chiropractic offices. As more people learn about the company's product, the easier it will be to form businesses around the product.

It was also great to see the company's medical director was invited to speak at the NAALT conference. Again, this brings more product and brand awareness and the opportunity to sell more units to a larger audience.

Distribution, product awareness, and brand awareness are how you build a company. The strategy is right. Keep at it.

uksausage

08/23/18 10:41 AM

#33854 RE: StockHighAlert- #33849

much easier to buy Actipatches from Bioelectronics for $30.

So now they are trying to get in to Malaysia with a product that has sold 5 units max in 2 years since it was cleared by the FDA.
If they did decide to use it who would make the units - no manufacturing facility and only a dozen left in inventory if that.